Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial. (Q34520055)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755608%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755608%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

0 references

chronic obstructive pulmonary disease

0 references

mechanical ventilation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755608%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

S Marghli

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755608%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M Belghith

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755608%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

L Besbes

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755608%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

S Elatrous

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755608%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

F Abroug

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755608%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755608%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755608%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

358

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755608%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

2020-2025

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755608%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

9298

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755608%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Epidemiology and treatment of chronic bronchitis and its exacerbations.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute exacerbations of COPD. How to evaluate severity and treat the underlying cause

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Single-blind comparative trial of trimethoprim-sulphamethoxazole and ampicillin in the treatment of exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of quinolones for the treatment of acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical studies in chronic bronchitis: a need for better definition and classification of severity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Do bacteria cause exacerbations of COPD?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of bacteria in exacerbations of COPD. A constructive view

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Complications of acute respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute exacerbations of chronic bronchitis: what role for the new fluoroquinolones?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Expanding uses of fluoroquinolones: opportunities and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907097-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(01)07097-0

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755608%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755608%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34520055&oldid=2046933982"